Q&A with the Editor-in-Chief, Dr. Emily Chew

  1. How does Ophthalmology Science differ from other ophthalmology titles?
    Ophthalmology Science is different because of the required perspective that focuses on the clinician to broaden their literacy in a number of areas including preclinical data, phase 1, 2 trials, basic science experiments, and more recently, bioinformatics that include both artificial intelligence/machine learning and big data science. Although the areas are broad, the clinical focus is maintained to ensure that the data, no matter the area of interest, are clinically relevant and comprehensible to the clinicians and that these studies may eventually lead future impact on clinical practice.
  2. How has your experience been so far as EIC?
    I have had the opportunity to serve on the editorial boards of Ophthalmology under the last two editors-in-chief. The transition to editor-in-chief has been supported by these mentors as well as the excellent editorial staff at Ophthalmology Science. It is a privilege to be able to lead the birth of a brand-new journal during an exciting time with a great deal of active research and the emphasis on big data and artificial intelligence. I look forward to the opportunity to guide the further growth of this new journal into a mainstream ophthalmology journal that brings diverse and clinically relevant studies to one of the largest readerships consisting of clinicians.
  3. What makes the editorial board, (including yourself) unique and diverse?
    The editorial board of Ophthalmology Science is strengthened by its diverse composition. The various ophthalmic subspecialties are well represented on the board by individuals who themselves are experienced researchers engaged in the peer-review process. The editorial board members come from 5 different areas of the globe, the United States, Canada, Australia, the Netherlands, and Singapore. Approximately 46% (18/39) of the board are women. In fact, the leadership provided by a female editor-in-chief is a rarity among ophthalmology journals.
  4. What are the goals and expectations of the journal over the next year?
    A major goal for the next year is to attract submissions from researchers who are conducting innovative and groundbreaking science, whether basic or clinical. We hope to be the journal in which translational research is highlighted. We have a special issue dedicated to artificial intelligence and big data science to be published in 2022. Currently, we have a deadline of March 31, 2022 for the initial draft submission. Great innovation occurring in this area could be impactful as we learn together the daunting path towards implementing the use of artificial intelligence into clinical care and clinical research.
  5. What are the most desired content types for the journal? How about most desired topics?
    As mentioned before, Ophthalmology Science is designed to address a number of diverse topics, including basic science experiments, preclinical data, early phase 1, 2 clinical trials, and bioinformatics. All such topics are welcomed for this journal. These studies should provide information that has potential clinical relevance. The most desired submissions are studies conducted with well thought-out designs and rigorous data collection and analyses. Transparency in providing detailed description of the methodology will allow for other researchers to test the reproducibility of such studies.
Dr Emily Chew
September 2022
Volume 2, Issue 3

Ophthalmology Science Frequently Asked Questions

The American Academy of Ophthalmology is expanding the Ophthalmology family of journals to include Ophthalmology Science, an online open access journal focused on publishing pre-clinical development, phase 1 and 2 clinical trials, laboratory-based work, ophthalmology informatics, and clinical science. Ophthalmology Science is the fourth of the Academy’s Ophthalmology® journals and its first open access journal. Click here to view the press release.

How do I submit to Ophthalmology Science?

View the Guide for Authors and online submission site. Contact the editorial office at [email protected] if you need help with the submission process.

If my manuscript is rejected by Ophthalmology, can it be considered for Ophthalmology Science?

Yes. If the Ophthalmology editorial board determines that a submission may be better suited for Ophthalmology Science, the authors will be offered the option of an expedited assessment with likely acceptance by the companion journal. Articles directly submitted to Ophthalmology Retina and Ophthalmology Glaucoma may also be given the same transfer option to Ophthalmology Science.

Does Ophthalmology Science have an Impact Factor?

It takes several years for a new journal to get an Impact Factor, and Ophthalmology Science will not publish until the first quarter of 2021. As soon as the journal is eligible, an application will be submitted to Clarivate Analytics, the organization that calculates the Impact Factor.

How are Ophthalmology Science articles discoverable?

When Ophthalmology Science articles are accepted, they will be searchable via Google/Google Scholar; publisher data shows that the majority of journal article searches nowadays are conducted using Google/Google Scholar. In addition, the accepted version of a manuscript is posted online 4-7 days after acceptance and articles are immediately searchable and citable through Google/Google Scholar. Ophthalmology Science will submit indexing applications (e.g., PubMed Central, Directory of Open Access Journals, Scopus) once eligible; new journals typically wait 12 to 24 months to apply for inclusion in various indices as most require either a 12-month publishing track record or minimum number of published articles before they will consider an application.

How often will Ophthalmology Science publish?

Ophthalmology Science articles upon acceptance are immediately and permanently free for everyone to read and download. This Open Access, online only journal will publish 4 issues each year. The inaugural issue will be available during the first quarter of 2021.

How do I subscribe to Ophthalmology Science?

Ophthalmology Science will be available online only and will be supported by article publishing charges (APCs), making the journal accessible to everyone without a subscription fee.

What are the article publishing charges for Ophthalmology Science?

Articles accepted for publication will be charged an open access publication fee, commonly called an Article Publishing Charge (APC). Refer to this link for pricing and Academy member discounts. Publishing open access means that millions of researchers globally will be able to find and read the work, completely free.

Advertisement